DiaMedica Therapeutics (DMAC) Depreciation & Amortization (CF) (2018 - 2026)
DiaMedica Therapeutics' (DMAC) quarterly Depreciation & Amortization (CF) came in at $11000.0 in Q1 2026, little changed year-on-year from $11000.0 in Q1 2025, and little changed quarter-over-quarter from $11000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
DiaMedica Therapeutics' Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $11000.0 for Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) changed 0.0% year-over-year to $11000.0 in Q1 2026; TTM through Mar 2026 was $43000.0, a 2.38% increase from a year earlier, with the FY2025 full-year figure at $43000.0, up 10.26% from the prior year.
- Depreciation & Amortization (CF) was little changed at $11000.0 in Q1 2026 per DMAC's latest filing, from $11000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $18000.0 in Q3 2025 and bottomed at $3000.0 in Q2 2025.
- The 5-year median for Depreciation & Amortization (CF) is $8000.0 (2023), against an average of $8705.9.
- Biggest YoY gain for Depreciation & Amortization (CF) was 80.0% in 2025; the steepest drop was 70.0% in 2025.
- Year by year, Depreciation & Amortization (CF) stood at $6000.0 in 2022, then surged by 33.33% to $8000.0 in 2023, then surged by 37.5% to $11000.0 in 2024, then changed by 0.0% to $11000.0 in 2025, then changed by 0.0% to $11000.0 in 2026.
- Per Business Quant, the three latest DMAC Depreciation & Amortization (CF) figures stand at $11000.0 (Q1 2026), $11000.0 (Q4 2025), and $18000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 2.20 Mn |
| 10 | DiaMedica Therapeutics | 364.72 Mn | 364.72 Mn | - | 11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Dec 31, 2025 | 11,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Sep 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Mar 31, 2025 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Dec 31, 2024 | 11,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Sep 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |